J. Gooya

发表

A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.

Damon L. Meyer, D. Jackson, Herren Wu, 2008, Cancer research.

S. Collins, S. Tsai, J. Keller, 1998 .

EBP deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo

V. Heath, K. Klarmann, J. Keller, 2004 .

Hematopoiesis and Thymic Apoptosis Are Not Affected by the Loss of Cdk2

H. Young, P. Kaldis, J. Keller, 2007, Molecular and Cellular Biology.

IL-3 Induces Inhibitor of DNA-Binding

S. Tsai, Hui Wang, W. Leeanansaksiri, 2005 .

Raf‐1 Protein is Required for Growth Factor‐Induced Proliferation of Primitive Hematopoietic Progenitors Stimulated with Synergistic Combinations of Cytokines

F. Ruscetti, J. Keller, K. Muszynski, 1997, Stem cells.

Cell-nonautonomous function of Id1 in the hematopoietic progenitor cell niche.

M. Ji, K. Klarmann, J. Keller, 2009, Blood.

Detection of growth factor receptor RNA in individual hematopoietic cells by in situ RT-PCR; comparison with RT-PCR.

J. Keller, S. Spence, J. Gooya, 2001, Journal of immunological methods.

Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth: comparison with other hematopoietins that use the gp130 receptor subunit.

J. Keller, F. Ruscetti, J. Gooya, 1996, Blood.

Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth.

S. Jacobsen, J. Keller, E. Sitnicka, 1994, Blood.

D3: a gene induced during myeloid cell differentiation of Linlo c-Kit+ Sca-1(+) progenitor cells.

S. Collins, S. Tsai, J. Keller, 1999, Blood.

Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptor.

D. Longo, J. Keller, R. Chizzonite, 1994, Blood.

Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2–positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib

D. Jackson, S. Coats, B. Jallal, 2009, Molecular Cancer Therapeutics.

Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo

M. Ji, K. Klarmann, J. Keller, 2008, Oncogene.

IL-3 Induces Inhibitor of DNA-Binding Protein-1 in Hemopoietic Progenitor Cells and Promotes Myeloid Cell Development1

S. Tsai, J. Keller, W. Leeanansaksiri, 2005, The Journal of Immunology.

Myeloid Cell Development Protein-1 in Hemopoietic Progenitor Cells IL-3 Induces Inhibitor of DNA-Binding

S. Tsai, J. Keller, W. Leeanansaksiri, 2005 .

EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.

A. Sood, D. Jackson, S. W. Kim, 2009, Journal of the National Cancer Institute.

DNA hypomethylation caused by Lsh deletion promotes erythroleukemia development

Jean A. Roayaei, Victorino R Briones, K. Muegge, 2008, Epigenetics.

Engraftment of SCID mice by human bone marrow hematopoietic cells cultured in vitro: an in vivo model for human gene transfer.

D. Longo, J. Keller, W. Murphy, 1995, Leukemia.

Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor.

D. Curiel, J. Keller, P. Schwarzenberger, 1996, Blood.

Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth

S. Jacobsen, J. Keller, E. Sitnicka, 1994 .

The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors.

S. Jacobsen, F. Ruscetti, J. Gooya, 1994, Experimental hematology.

progenitor/stem cell growth hematopoietic protein-1 alpha and transforming growth factor beta on Distinct and overlapping direct effects of macrophage inflammatory

S. Jacobsen, J. Keller, E. Sitnicka, 2011 .

Interleukin-1α protects against the toxicity associated with combined radiation and drug therapy

M. Evans, J. Gooya, Kovacs Cj, 1991 .

Altered radioprotective properties of interleukin I alpha (IL-1) in non-hematologic tumor-bearing animals.

K. McGowan, M. Evans, C. Kovacs, 1991, International journal of radiation oncology, biology, physics.

Inhibition of Growth by p205: A Nuclear Protein and Putative Tumor Suppressor Expressed during Myeloid Cell Differentiation

Mark H. Smith, Benyam Asefa, J. Keller, 2004, Stem cells.

EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma

A. Sood, D. Jackson, Jeong-Won Lee, 2010, Clinical Cancer Research.

C/EBPα deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo

V. Heath, Peter F. Johnson, K. Klarmann, 2004 .

C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo.

V. Heath, Peter F. Johnson, K. Klarmann, 2004, Blood.

C/EBPalpha determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation.

Peter F. Johnson, A. Friedman, J. Keller, 2006, Blood.

Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells

F. Ruscetti, U. Rapp, G. Heidecker, 1995, The Journal of experimental medicine.

The effect of c-raf antisense oligonucleotides on growth factor-induced proliferation of hematopoietic cells.

U. Rapp, G. Heidecker, J. Keller, 1996, Current topics in microbiology and immunology.

Temporal recovery of short-term repopulating HSC subpopulations in marrow following schedule-dependent administrations of IL-1 alpha and M-CSF.

M. Evans, C. Kovacs, R. Johnke, 1995, Experimental Hematology.

Tumour‐induced altered gastrointestinal steady‐states: absence of MHC restriction in the paraneoplastic gastrointestine

M. Langweiler, M. Evans, C. Kovacs, 1989, Cell and tissue kinetics.

Abstract 2776: MEDI5752: A novel bispecific antibody that preferentially targets CTLA-4 on PD-1 expressing T-cells

Daniel J. Freeman, Des C. Jones, G. Browne, 2018, Immunology.